Cyclophosphamide - cyclophosphamide
Navigation: NDC > Supplier starting with: B > BAXTER HEALTHCARE CORPORATION| Field | Value |
|---|---|
| NDC Code: | 10019-955 |
| Proprietary Name: | Cyclophosphamide |
| Suffix: | |
| Non-Proprietary Name: | cyclophosphamide |
| Dosage Form: | INJECTION, POWDER, FOR SOLUTION |
| Method: | INTRAVENOUS; ORAL |
| Original Marketing Date: | 21-05-2008 |
| Category Name: | ANDA |
| Application Number: | ANDA040745 |
| Labeler: | BAXTER HEALTHCARE CORPORATION |
| Substance Name: | CYCLOPHOSPHAMIDE |
| Active Numerator Strength: | 500 |
| Active Ingredient Unit: | mg/25mL |
| Pharm Classes: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| DEA Schedule: |